Sign in to view content

Early Insights From Real-World Use of Aflibercept 8 mg Among Eyes With Diabetic Macular Edema SwitchingFrom Other Anti-VEGF Agents

Michael Javaheri, MD

Video
Published 2025

Related

Level of Diabetic Retinopathy Severity Correlates to Degree of Quadrant Asymmetry in Both Single and Averaged Imaged OCTA Metrics
Jesse J Jung, MD, FASRS
Annual Meeting Talks
2022
Health Disparities in Lapses in Diabetic Retinopathy Care
Cindy X Cai, MD
Annual Meeting Talks
2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more